Sinovac Biotech Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

Completed

Conditions: Hand, Foot and Mouth Disease

First Posted Date: 2017-09-13

Last Posted Date: 2017-09-13

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 343

Registration Number: NCT03281174

Locations: 🇨🇳
Sheyang Center for Disease Control and Prevention, Yancheng, Jiangsu, China

Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine

Phase 4

Completed

Conditions: Hand, Foot and Mouth Disease

Interventions: Biological: EV71 vaccine

First Posted Date: 2017-09-11

Last Posted Date: 2019-01-02

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 120

Registration Number: NCT03278132

Locations: 🇨🇳
Shangyu District Center for Disease Control and Prevention, Shaoxing, Zhejiang, China

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

Phase 4

Completed

Conditions: Hand, Foot and Mouth Disease

Interventions: Biological: EV71 Vaccine only
Biological: Concomitant administration of EV71 vaccine with EPI vaccines
Biological: Single injection of EPI vaccine

First Posted Date: 2017-09-06

Last Posted Date: 2021-07-29

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 780

Registration Number: NCT03274102

Locations: 🇨🇳
Dongguan Municipal Center for Disease Control and Prevention, Dongguan, Guangdong, China

Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine

Phase 1

Completed

Conditions: Poliomyelitis

Interventions: Biological: Single-dose regimen of medium dosage investigational sIPV
Biological: Three-dose regimen of high dosage investigational sIPV
Biological: Single-dose regimen of high dosage investigational sIPV
Biological: Three-dose regimen of medium dosage investigational sIPV
Biological: Three-dose regimen of commercialized IPV
Biological: Three-dose regimen of low dosage investigational sIPV
Biological: Three-dose regimen of commercialized sIPV

First Posted Date: 2016-12-07

Last Posted Date: 2017-07-26

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 708

Registration Number: NCT02985320

Locations: 🇨🇳
Pizhou City Center for Disease Control and Prevention, Xuzhou, Jiangsu, China

Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly

Phase 3

Completed

Conditions: Pneumococcal Infections

Interventions: Biological: investigational 23-valent PPV
Biological: control 23-valent PPV

First Posted Date: 2015-05-22

Last Posted Date: 2017-05-03

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 1760

Registration Number: NCT02451969

Locations: 🇨🇳
Kaifeng County Center for Disease Control and Prevention, Kaifeng, Henan, China

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine

Phase 4

Completed

Conditions: Hepatitis B
Hepatitis A

Interventions: Biological: Inactivated Hepatitis A vaccine (HAV)
Biological: Combined hepatitis A and hepatitis B vaccine (HABV)

First Posted Date: 2015-05-15

Last Posted Date: 2021-07-27

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 301

Registration Number: NCT02445703

Locations: 🇨🇳
Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan, China

The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine

Phase 4

Completed

Conditions: Influenza

Interventions: Biological: trivalent seasonal influenza vaccine

First Posted Date: 2014-10-21

Last Posted Date: 2015-09-21

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 182

Registration Number: NCT02269852

Locations: 🇨🇳
Guzhen Center for Diseases Control and Prevention, Bengbu, Anhui, China

The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children

Completed

Conditions: Hepatitis A

Interventions: Biological: Attenuated alive HAV vaccine
Biological: Inactivated HAV vaccine

First Posted Date: 2013-12-05

Last Posted Date: 2016-07-14

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 332

Registration Number: NCT02002065

Locations: 🇨🇳
Tianjin center for disease prevention and control, Tianjin, China

A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Completed

Conditions: Hand, Foot and Mouth Disease

Interventions: Biological: EV71 vaccine

First Posted Date: 2013-12-04

Last Posted Date: 2022-05-26

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 10077

Registration Number: NCT02001233

Locations: 🇨🇳
Ganyu, Lianyungang, Jiangsu, China
🇨🇳
Taixing, Taizhou, Jiangsu, China
🇨🇳
Sheyang, Yancheng, Jiangsu, China

Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults

Phase 4

Completed

Conditions: Hepatitis A

Interventions: Biological: Inactivated HAV vaccine
Biological: Live attenuated HAV vaccine

First Posted Date: 2013-05-31

Last Posted Date: 2015-05-14

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 239

Registration Number: NCT01865968

Locations: 🇨🇳
Nanchang Center for Disease prevention and Control, Nanchang, Jiangxi, China

Home Terms & Conditions Privacy Policy